DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Medroxyprogesterone Acetate is a drug marketed by Amphastar Pharms Inc, Cipla, Mylan Labs Ltd, Sandoz Inc, Sun Pharm, Teva Pharms Usa, Barr, Duramed Pharms Barr, and Upsher Smith Labs. and is included in twelve NDAs.
The generic ingredient in MEDROXYPROGESTERONE ACETATE is medroxyprogesterone acetate. There are twenty drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the medroxyprogesterone acetate profile page.
A generic version of MEDROXYPROGESTERONE ACETATE was approved as medroxyprogesterone acetate by BARR on August 9th, 1996.
Summary for MEDROXYPROGESTERONE ACETATE
Recent Clinical Trials for MEDROXYPROGESTERONE ACETATE
Identify potential brand extensions & 505(b)(2) entrants
|Centre Hospitalier Intercommunal Creteil||Phase 3|
|Nationwide Children's Hospital||Phase 4|
|Ohio State University||Phase 4|
Pharmacology for MEDROXYPROGESTERONE ACETATE
|Drug Class||Progestin |